Holen Sie sich die Stockscreener-App
4.80
2.56%
0.12
Handel nachbörslich:
4.80
Schlusskurs vom Vortag:
$4.68
Offen:
$4.75
24-Stunden-Volumen:
24,448
Relative Volume:
1.43
Marktkapitalisierung:
$43.42M
Einnahmen:
$23.84M
Nettoeinkommen (Verlust:
$-3.81M
KGV:
-9.60
EPS:
-0.5
Netto-Cashflow:
$-713.00K
1W Leistung:
+1.27%
1M Leistung:
-21.05%
6M Leistung:
-26.38%
1J Leistung:
+29.73%
1-Tages-Spanne:
$4.72
$5.36
1-Wochen-Bereich:
$4.52
$5.36
52-Wochen-Spanne:
$3.55
$7.60
Immucell Corp Stock (ICCC) Company Profile
Firmenname
Immucell Corp
Sektor
Branche
Telefon
(207) 878-2770
Adresse
56 EVERGREEN DR, PORTLAND, ME
Vergleichen Sie ICCC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ICCC
Immucell Corp
|
4.80 | 42.33M | 23.84M | -3.81M | -713.00K | -0.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.17 | 109.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.61 | 82.75B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.12 | 56.78B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.63 | 56.52B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.51 | 44.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Immucell Corp Aktie (ICCC) Neueste Nachrichten
ImmuCell Corp (ICCC) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... By GuruFocus - Investing.com Canada
Will ImmuCell Corporation stock sustain high P E ratiosM&A Rumor & Safe Investment Capital Preservation Plans - newser.com
ICCC Stock Down Despite Y/Y Q3 Earnings Improvement & Margin Strength - Yahoo Finance
Why ImmuCell Corporation stock is a must watch in 2025Trade Risk Report & Daily Profit Maximizing Tips - newser.com
Will ImmuCell Corporation (IUL) stock benefit from sector leadershipJuly 2025 Drop Watch & Fast Moving Trade Plans - newser.com
Will ImmuCell Corporation bounce back from current supportJuly 2025 Price Swings & Capital Efficiency Focused Strategies - newser.com
How to monitor ImmuCell Corporation with trend dashboards2025 Investor Takeaways & Safe Capital Growth Stock Tips - newser.com
ImmuCell Corporation (NASDAQ:ICCC) Q3 2025 Earnings Call Transcript - Insider Monkey
ImmuCell Corp. Experiences Valuation Adjustment Amidst Strong Yearly Performance Metrics - Markets Mojo
What catalysts could drive ImmuCell Corporation stock higherWeekly Risk Report & Community Consensus Trade Signals - newser.com
Earnings call transcript: ImmuCell Q3 2025 sees stock dip amid revenue fall - Investing.com Canada
ImmuCell Q3 2025 slides: Improved margins despite revenue dip, Re-Tain awaits FDA - Investing.com
How ImmuCell Corporation (IUL) stock valuation compares with sectorJuly 2025 Trends & Long-Term Growth Stock Strategies - Fundação Cultural do Pará
ImmuCell Corporation Reports Third Quarter 2025 Financial Results with Significant Year-Over-Year Improvements in Net Income and Gross Margin - Quiver Quantitative
[8-K] IMMUCELL CORP /DE/ Reports Material Event | ICCC SEC FilingForm 8-K - Stock Titan
ImmuCell (NASDAQ: ICCC) posts $1.8M net income for nine months; gross margin at 42.6% - Stock Titan
Financial Review: CompuMed (OTCMKTS:CMPD) vs. ImmuCell (NASDAQ:ICCC) - Defense World
Multi asset correlation models including ImmuCell CorporationJuly 2025 Sentiment & Fast Exit Strategy with Risk Control - newser.com
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025 - The Manila Times
ImmuCell (NASDAQ: ICCC) schedules third-quarter results for Nov 13; call Nov 14 - Stock Titan
Why ImmuCell Corporation stock is seen as undervaluedWeekly Earnings Recap & Verified Short-Term Plans - newser.com
What MACD signals say about ImmuCell CorporationJuly 2025 Selloffs & Verified Entry Point Detection - newser.com
ImmuCell appoints Olivier te Boekhorst as new CEO - Investing.com
ImmuCell appoints Olivier te Boekhorst as new CEO By Investing.com - Investing.com Canada
ImmuCell Corporation Announces Appointment of New CEO Olivier te Boekhorst and Board Changes - Quiver Quantitative
ImmuCell (NASDAQ: ICCC) names Olivier te Boekhorst CEO, effective Nov 1, 2025 - Stock Titan
ImmuCell (NASDAQ:ICCC) Stock Passes Above 200 Day Moving AverageHere's What Happened - MarketBeat
Will ImmuCell Corporation stock rally after Fed decisionsProfit Target & Fast Gain Swing Trade Alerts - newser.com
Is ImmuCell Corporation stock positioned for long term growthSwing Trade & Reliable Intraday Trade Plans - newser.com
Will ImmuCell Corporation stock gain from lower inflationJuly 2025 Pullbacks & Risk Adjusted Buy/Sell Alerts - newser.com
Finanzdaten der Immucell Corp-Aktie (ICCC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.76%
2.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):